Published in Diabetologia on April 01, 2004
Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci U S A (2006) 2.59
Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab (2006) 2.09
The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res (2009) 2.08
Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes (2009) 1.53
beta-Cell-specific overexpression of glutathione peroxidase preserves intranuclear MafA and reverses diabetes in db/db mice. Endocrinology (2009) 1.49
High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition. Diabetes (2011) 1.11
Suppression of KATP channel activity protects murine pancreatic beta cells against oxidative stress. J Clin Invest (2009) 1.00
Novel role of curcumin in the prevention of cytokine-induced islet death in vitro and diabetogenesis in vivo. Br J Pharmacol (2008) 0.97
Androgen excess produces systemic oxidative stress and predisposes to beta-cell failure in female mice. PLoS One (2010) 0.91
Effects of early postnatal hyperglycaemia on renal cortex maturity, endothelial nitric oxide synthase expression and nephron deficit in mice. Int J Exp Pathol (2008) 0.83
High plasma 5-hydroxyindole-3-acetic acid concentrations in subjects with metabolic syndrome. Diabetes Care (2011) 0.81
T-cell vaccination leads to suppression of intrapancreatic Th17 cells through Stat3-mediated RORγt inhibition in autoimmune diabetes. Cell Res (2011) 0.80
Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model. J Alzheimers Dis (2015) 0.77
Streptozotocin Induced Acute Clinical Effects in Rabbits (Oryctolagus cuniculus). Iran J Pathol (2015) 0.75
Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. VII. Immune-complex glomerulonephritis. J Immunol (1983) 1.53
Autoimmunization and lymphomagenesis in parent to F1 combinations differing at the major histocompatibility complex: model for spontaneous disease caused by altered self-antigens? Transplant Rev (1976) 1.50
Chronic allogeneic disease. II. Development of lymphomas. J Exp Med (1970) 1.46
GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes (1998) 1.36
Immunologic induction of malignant lymphoma: genetic factors in the graft-versus-host model. J Natl Cancer Inst (1972) 1.14
Immunoblastic lymphadenopathy, systemic lupus erythematosus, and related disorders. Possible pathogenetic pathways. Am J Clin Pathol (1979) 1.10
Chronic allogeneic disease. 3. Genetic requirements for the induction of glomerulonephritis. J Exp Med (1972) 1.08
Studies on the mechanism of drug sensitization: T-cell-dependent popliteal lymph node reaction to diphenylhydantoin. Clin Immunol Immunopathol (1981) 1.02
Zinc sulphate induces metallothionein in pancreatic islets of mice and protects against diabetes induced by multiple low doses of streptozotocin. Diabetologia (2000) 0.98
Pathogenesis of graft-versus-host reactions (GVHR) and GVH-like diseases. J Invest Dermatol (1985) 0.96
Cellular immunity in the mouse. IV. Altered thymic-dependent lymphocyte reactivity in the chronic graft vs host reaction and leukemia virus activation. Cell Immunol (1975) 0.89
Immunosuppression and malignant lymphomas in graft-versus-host reactions. Cancer Res (1973) 0.88
Over 95 per cent sensitization against allogeneic leukocytes following single massive blood transfusion. Vox Sang (1975) 0.87
Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells. J Exp Med (1984) 0.85
Nonresponsiveness to the male antigen H-Y in H-2 I-A-mutant B6.C-H-2bm12 is not caused by defective antigen presentation. J Immunol (1983) 0.85
Predictive immunotoxicological test systems: suitability of the popliteal lymph node assay in mice and rats. Crit Rev Toxicol (1995) 0.84
Progress toward standardization of cytoplasmic islet cell-antibody assay. Diabetes (1987) 0.84
Immunity to D-penicillamine: genetic, cellular, and chemical requirements for induction of popliteal lymph node enlargement in the mouse. J Immunol (1987) 0.84
Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro. Exp Clin Endocrinol Diabetes (2004) 0.83
Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays. Diabetologia (1990) 0.82
Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults. Diabetologia (1984) 0.82
Immunologic induction of malignant lymphoma: identification of donor and host tumors in the graft-versus-host model. J Natl Cancer Inst (1975) 0.82
Experimental benefit of moxonidine on glucose metabolism and insulin secretion in the fructose-fed rat. J Hypertens Suppl (1997) 0.80
Immunology and Diabetes Workshop: report on the Third International (Stage 3) Workshop on the Standardisation of Cytoplasmic Islet Cell Antibodies. Held in New York, New York, October 1987. Diabetologia (1988) 0.80
Prevention of high- and low-dose STZ-induced diabetes with D-glucose and 5-thio-D-glucose. Diabetes (1993) 0.79
Specific immunity to streptozocin. Cellular requirements for induction of lymphoproliferation. Diabetes (1988) 0.79
T cell-dependent B cell lymphoproliferation and activation induced by the drug diphenylhydantoin. Adv Exp Med Biol (1982) 0.79
Differential immunogenicity of D- and K-end antigens and its possible significance for HL-A. Transplantation (1972) 0.78
Glucose transporter 2 expression: prevention of streptozotocin-induced reduction in beta-cells with 5-thio-D-glucose. Exp Clin Endocrinol Diabetes (1995) 0.77
Induction of immune complex glomerulonephritis in F1 hybrid mice: superiority of cortisone-resistant parental thymocytes over spleen cells. Cell Immunol (1974) 0.77
Graft-versus-host reaction: a pathogenetic principle for the development of drug allergy, autoimmunity, and malignant lymphoma in non-chimeric individuals. Hypothesis. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1976) 0.77
Metallothionein in isolated pancreatic islets of mice: induction by zinc and streptozotocin, a naturally occurring diabetogen. Arch Toxicol (1993) 0.77
Immunosuppression and neoplasia. I. A critical review of experimental carcinogenesis and the immunesurveillance theory. Klin Wochenschr (1973) 0.76
Zincsulphate induced metallothionein in pancreatic islets and protected against the diabetogenic toxin streptozotocin. Talanta (1998) 0.76
Metallothionein: in vitro induction with zinc and streptozotocin in pancreatic islets of mice. Exp Clin Endocrinol Diabetes (1995) 0.76
[Immunogenetic requirements for the demonstration of a new form of immunocomplex-glomerulonephritis and malignant lymphoma in a chronic allogenic disease model]. Verh Dtsch Ges Inn Med (1971) 0.76
Immunologic induction of reticulum cell sarcoma: donor-type lymphomas in the graft-versus-host model. Eur J Immunol (1976) 0.75
The occurrence of spontaneous immune-complex glomerulonephritis in Han: NMRI mice. Contrib Nephrol (1980) 0.75
Cancer caused by an inherited selective defect in immunological surveillance. Lancet (1973) 0.75
Essential similarity between graft-versus-host disease and viral infections. Transplantation (1976) 0.75
T cell-dependent class II major histocompatibility complex antigen expression in vivo induced by the diabetogen streptozotocin. Immunobiology (1989) 0.75
HL-A phenotype and haplotype frequencies in a German population. Tissue Antigens (1974) 0.75
Immunosuppression and neoplasia. II. Is deficient immunesurveillance the only mechanism by which immunosuppression promotes neoplasia? A speculative review. Klin Wochenschr (1973) 0.75
Immunology and diabetes--on the search for triggers and effectors. Immunol Today (1989) 0.75
Reactivation of radioresistant F1-specific parental cells by F1 T cells. Preliminary evidence for a semiallogeneic T-T cell interaction. Transplantation (1976) 0.75
The popliteal lymphnode assay (PLNA) in rodents: a simple functional test for detecting sensitizing effects of xenobiotics. Arch Toxicol Suppl (1989) 0.75
[Immunogenetic studies on the pathogenesis of lymphoreticular neoplasms in a chronic allogenic disease model]. Verh Dtsch Ges Inn Med (1971) 0.75
Lymphomagenesis and autoimmunization caused by reactions of T-lymphocytes to incompatible structures of the major histocompatibility complex: a concept of pathogenesis. Recent Results Cancer Res (1978) 0.75
[Inflammatory stage of incontinentia pigmenti (Bloch-Sulzberger syndrome)]. Hautarzt (2006) 0.75
GVHD, a model for Spanish toxic oil syndrome? Lancet (1984) 0.75
Comparison of a new anti-glutamic acid decarboxylase (GAD) enzyme-linked immunosorbent assay (ELISA) with radioimmunoassay methods: a multicenter study. Horm Metab Res (1997) 0.75
[A severe course of bullous pemphigoid in a young man]. Hautarzt (2006) 0.75